Compare TDY & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TDY | IQV |
|---|---|---|
| Founded | 1960 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9B | 34.6B |
| IPO Year | 2000 | 2013 |
| Metric | TDY | IQV |
|---|---|---|
| Price | $650.94 | $207.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 16 |
| Target Price | ★ $693.71 | $227.13 |
| AVG Volume (30 Days) | 302.0K | ★ 1.5M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.70 | 4.67 |
| EPS | ★ 4.85 | 1.61 |
| Revenue | $1,020,400,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | $5.54 | $6.77 |
| Revenue Next Year | $5.08 | $5.89 |
| P/E Ratio | $134.54 | ★ $128.19 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $483.02 | $154.50 |
| 52 Week High | $693.38 | $247.05 |
| Indicator | TDY | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 59.05 | 73.43 |
| Support Level | $627.29 | $159.91 |
| Resistance Level | $679.74 | $209.48 |
| Average True Range (ATR) | 18.49 | 6.76 |
| MACD | 5.08 | 2.83 |
| Stochastic Oscillator | 67.27 | 97.29 |
Teledyne Technologies Inc provides enabling technologies to sense, analyze and distribute information for industrial growth markets that require advanced technology and high reliability. The firm operates in four segments: Digital Imaging, Instrumentation, Aerospace and Defense Electronics, and Engineered Systems. The Digital Imaging segment, that derives maximum revenue, includes high-performance sensors, cameras and systems, within the visible, infrared and X-ray spectra for use in industrial, government and medical applications, as well as MEMS and high-performance, high-reliability semiconductors including analog-to-digital and digital-to-analog converters. Geographically, the company operates in United States, Europe, Asia, and All other.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.